In vivo dog intestinal precipitation of mebendazole: A basic BCS class II drug

Molecular Pharmaceutics

Volumn 9, Issue 10, 2012, Pages 2903-2911

  Carlert, Sara ^a   Åkesson, Pernilla ^b   Jerndal, Gunilla ^b   Lindfors, Lennart ^b   Lennernäs, Hans ^a   Abrahamsson, Bertil ^b  

^a UPPSALA UNIVERSITY   (Sweden)

^b ASTRAZENECA R AND D   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

MEBENDAZOLE;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COMPUTER MODEL; CONTROLLED STUDY; DOG; DRUG ABSORPTION; DRUG SOLUBILITY; FEMALE; IN VITRO STUDY; IN VIVO STUDY; INTESTINE; INTESTINE FLUID; MALE; NONHUMAN; PRIORITY JOURNAL; SMALL INTESTINE;

EID: 84870170578     PISSN: 15438384     EISSN: 15438392     Source Type: Journal    
DOI: 10.1021/mp300224h     Document Type: Article

References (39)

1. Carlert, S.; Palsson, A.; Hanisch, G.; Von Corswant, C.; Nilsson, C.; Lindfors, L.; Lennernas, H.; Abrahamsson, B. Predicting intestinal precipitation-A case example for a basic BCS class II drug Pharm. Res. 2010, 27, 2119-2130
2. Psachoulias, D.; Vertzoni, M.; Goumas, K.; Kalioras, V.; Beato, S.; Butler, J.; Reppas, C. Precipitation in and supersaturation of contents of the upper small intestine after administration of two weak bases to fasted adults Pharm. Res. 2011, 28, 3145-3158
3. Bergman, E.; Forsell, P.; Persson, E. M.; Knutson, L.; Dickinson, P.; Smith, R.; Swaisland, H.; Farmer, M. R.; Cantarini, M. V.; Lennernas, H. Pharmacokinetics of gefitinib in humans: The influence of gastrointestinal factors Int. J. Pharm. 2007, 341, 134-142
4. Takano, R.; Takata, N.; Saito, R.; Furumoto, K.; Higo, S.; Hayashi, Y.; MacHida, M.; Aso, Y.; Yamashita, S. Quantitative analysis of the effect of supersaturation on in vivo drug absorption Mol. Pharmaceutics 2010, 7, 1431-1440
5. Sugano, K. Computational oral absorption simulation of free base drugs Int. J. Pharm. 2010, 398, 73-82
6. Shono, Y.; Jantratid, E.; Dressman, J. B. Precipitation in the small intestine may play a more important role in the in vivo performance of poorly soluble weak bases in the fasted state: Case example nelfinavir Eur. J. Pharm. Biopharm. 2011, 79, 349-356
7. Diaz, D.; Bernad Bernad, M. J.; Gracia-Mora, J.; Escobar Llanos, C. M. Solubility, 1H-NMR, and molecular mechanics of mebendazole with different cyclodextrins Drug Dev. Ind. Pharm. 1999, 25, 111-115
8. Nielsen, L. S.; Slok, F.; Bundgaard, H. N-alkoxycarbonyl prodrugs of mebendazole with increased water solubility Int. J. Pharm. 1994, 102, 231-239
9. Charoenlarp, P.; Waikagul, J.; Muennoo, C.; Srinophakun, S.; Kitayaporn, D. Efficacy of single-dose mebendazole, polymorphic forms A and C, in the treatment of hookworm and Trichuris infections Southeast Asian J. Trop. Med. Public Health 1993, 24, 712-716
10. Dawson, M.; Braithwaite, P. A.; Roberts, M. S.; Watson, T. R. The pharmacokinetics and bioavailability of a tracer dose of [3H]-mebendazole in man Br. J. Clin. Pharmacol. 1985, 19, 79-86
11. Dawson, M.; Watson, T. R. The effect of dose form on the bioavailability of mebendazole in man Br. J. Clin. Pharmacol. 1985, 19, 87-90
12. Chiba, Y.; Kohri, N.; Iseki, K.; Miyazaki, K. Improvement of dissolution and bioavailability for mebendazole, an agent for human echinococcosis, by preparing solid dispersion with polyethylene glycol Chem. Pharm. Bull. 1991, 39, 2158-2160
13. Brusau, E. V.; Cami, G. E.; Narda, G. E.; Cuffini, S.; Ayala, A. P.; Ellena, J. Synthesis and characterization of a new mebendazole salt: Mebendazole hydrochloride J. Pharm. Sci. 2008, 97, 542-552
14. Daniel-Mwambete, K.; Torrado, S.; Cuesta-Bandera, C.; Ponce-Gordo, F.; Torrado, J. J. The effect of solubilization on the oral bioavailability of three benzimidazole carbamate drugs Int. J. Pharm. 2004, 272, 29-36
15. Nielsen, L. S. Improved peroral bioavailability of mebendazole in rabbits by administration of various N-alkoxycarbonyl derivatives of mebendazole Int. J. Pharm. 1994, 104, 175-179
16. Lindfors, L.; Forssen, S.; Skantze, P.; Skantze, U.; Zackrisson, A.; Olsson, U. Amorphous drug nanosuspensions. 2. Experimental determination of bulk monomer concentrations Langmuir 2006, 22, 911-916
17. De Villiers, M. M.; Terblanche, R. J.; Liebenberg, W.; Swanepoel, E.; Dekker, T. G.; Song, M. Variable-temperature X-ray powder diffraction analysis of the crystal transformation of the pharmaceutically preferred polymorph C of mebendazole J. Pharm. Biomed. Anal. 2005, 38, 435-441
18. Costa, J.; Fresno, M.; Guzman, L.; Igual, A.; Oliva, J.; Vidal, P.; Perez, A.; Pujol, M. Polymorphic forms of mebendazole: Analytical aspects and toxicity Cir. Farm. 1991, 49, 415-424
19. Liebenberg, W.; Dekker, T. G.; Lotter, A. P.; De Villiers, M. M. Identification of the mebendazole polymorphic form present in raw materials and tablets available in South Africa Drug Dev. Ind. Pharm. 1998, 24, 485-488
20. The United States Pharmacopeia (USP 32); United States Pharmacopeial Convention, Inc.: Rockville, 2008.
21. Persson, E. M.; Nilsson, R. G.; Hansson, G. I.; Lofgren, L. J.; Liback, F.; Knutson, L.; Abrahamsson, B.; Lennernas, H. A clinical single-pass perfusion investigation of the dynamic in vivo secretory response to a dietary meal in human proximal small intestine Pharm. Res. 2006, 23, 742-751
22. Polentarutti, B.; Albery, T.; Dressman, J.; Abrahamsson, B. Modification of gastric pH in the fasted dog J. Pharm. Pharmacol. 2010, 62, 462-469
23. Kalantzi, L.; Persson, E.; Polentarutti, B.; Abrahamsson, B.; Reppas, C. Canine intestinal contents vs. simulated media for the assessment of solubility of two weak bases in the human small intestinal contents Pharm. Res. 2006, 23, 1373-1381
24. Kitaigorodsky, A. I. Molecular Crystals and Molecules; Academic Press: New York, 1973.
25. Langenbucher, F. Numerical convolution/deconvolution as a tool for correlating in vitro with in vivo drug availability Pharm. Ind. 1982, 44, 1166-1172
26. Agoram, B.; Woltosz, W. S.; Bolger, M. B. Predicting the impact of physiological and biochemical processes on oral drug bioavailability Adv. Drug Delivery Rev. 2001, 50, S41-S67
27. Knutson, T.; Fridblom, P.; Ahlstrom, H.; Magnusson, A.; Tannergren, C.; Lennernas, H. Increased Understanding of Intestinal Drug Permeability Determined by the LOC-I-GUT Approach Using Multislice Computed Tomography Mol. Pharmaceutics 2009, 6, 2-10
28. Cao, X.; Leyva, N.; Anderson, S. R.; Hancock, B. C. Use of prediction methods to estimate true density of active pharmaceutical ingredients Int. J. Pharm. 2008, 355, 231-237
29. Avdeef, A. Leakiness and Size Exclusion of Paracellular Channels in Cultured Epithelial Cell Monolayers-Interlaboratory Comparison Pharm. Res. 2010, 27, 480-489
30. Linnankoski, J.; Makela, J. M.; Ranta, V.; Urtti, A.; Yliperttula, M. Computational prediction of oral drug absorption based on absorption rate constants in humans J. Med. Chem. 2006, 49, 3674-3681
31. Winiwarter, S.; Bonham, N. M.; Ax, F.; Hallberg, A.; Lennernas, H.; Karlen, A. Correlation of human jejunal permeability (in vivo) of drugs with experimentally and theoretically derived parameters: A multivariate data analysis approach J. Med. Chem. 1998, 41, 4939-4949
32. Linnankoski, J.; Ranta, V.; Yliperttula, M.; Urtti, A. Passive oral drug absorption can be predicted more reliably by experimental than computational models-Fact or myth Eur. J. Pharm. Sci. 2008, 34, 129-139
33. Personal communication: Amidon, G. L.; Yamashita, S. Dog Peff results for a number of pharmaceutical drugs.
34. Sun, D.; Lennernas, H.; Welage, L. S.; Barnett, J. L.; Landowski, C. P.; Foster, D.; Fleisher, D.; Lee, K.-.; Amidon, G. L. Comparison of human duodenum and Caco-2 gene expression profiles for 12,000 gene sequences tags and correlation with permeability of 26 drugs Pharm. Res. 2002, 19, 1400-1416
35. Adhiyaman, R.; Basu, S. K. Crystal modification of dipyridamole using different solvents and crystallization conditions Int. J. Pharm. 2006, 321, 27-34
36. Viseras, C.; Ismail Salem, I.; Rodriguez Galan, I. C.; Cerezo Galan, A.; López Galindo, A. The effect of recrystallization on the crystal growth, melting point and solubility of ketoconazole Thermochim. Acta 1995, 268, 143-151
37. Lindfors, L.; Forssen, S.; Westergren, J.; Olsson, U. Nucleation and crystal growth in supersaturated solutions of a model drug J. Colloid Interface Sci. 2008, 325, 404-413
38. Veintemillas-Verdaguer, S.; Osuna Esteban, S.; Herrero, M. A. The effect of stirring on sodium chlorate crystallization under symmetry breaking conditions J. Cryst. Growth 2007, 303, 562-567
39. Myerson, A. S.; Ginde, R. Crystals, Crystal Growth, and Nucleation; In Handbook of Industrial Crystallization, 2 nd ed.; Myerson, E. S., Ed.; Butterworth-Heinemann: Woburn, 2002; pp 52-53.